Pain and Smoking Study - Interactive Voice Response
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVA Office of Research and Development
About this trial
PASS2 aims to expand upon the recently completed study (PASS intervention), which tested the telephone delivery of a cognitive behavioral intervention (CBI). This study will use Interactive Voice Response (IVR) to optimize the intervention's effectiveness for smoking cessation among Veteran smokers with chronic pain.
Eligibility criteria
Qualifiers
being an enrolled Veteran at VACHS;
current tobacco use;
willingness to make a quit attempt;
significant chronic pain defined as >/=4 on the pain intensity portion of the Brief Pain Inventory (BPI) for more than 90 days.
Disqualifiers
active diagnosis of dementia or psychosis in medical record;
severely impaired hearing or speech;
lack of telephone access;
enrollment in concurrent research study that might affect main outcomes of this study;
Trial design
Treatments tested in this trial
- PASS-IVR
- Treatment as Usual
Treatment groups
220 Participants
are divided into 2 treatment groupsLocations
1VA Connecticut Healthcare System West Haven Campus, West Haven, CT06516-2770, West HavenConnecticut, United States
Sponsors and collaborators
VA Office of Research and Development
Lead sponsor
Source ClinicalTrials.gov